Prognostic and Predictive Clinical, Pathological and Molecular Markers for Oral Squamous Cell Carcinoma: review of articles

Authors

1 Assistant professor, Department of Oral and Maxillofacial Pathology, School of Dentistry& Oral and Dental Diseases Research Center, Kerman University of Medical Sciences, Kerman, Iran

2 Associate professor, Department of Oral and Maxillofacial Pathology, School of Dentistry & Oral and Dental Diseases Research Center , Kerman University of Medical Sciences, Kerman, Iran

Abstract

Approximately 90% of all head and neck malignancies and 94% of oral malignancies are squamous cell carcinoma (SCC). Tobacco smoking is considered as the most important causative agent for SCC. Despite aggressive and multidisciplinary treatment approaches, there has been no significant improvement in 5-year survival over the past 20 years. Several prognostic and predictive clinical, pathological and molecular factors have been introduced for SCC. We herein review some of these prognostic factors.

  1. Menzin J, Lines LM, Manning LN. The economics of squamous cell carcinoma of the head and neck. Current Opinion in Otolaryngology & Head and Neck Surgery 2007; 15:68–73.
  2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74–108.
  3. Neville BW, Dam DD, Allen CM, Bouquot JE. Oral and maxillofacial pathology. 3rd ed. Saunders; 2009:356-359.
  4. Wyss A, Hashibe M, Chuang SC, Lee YC, Zhang ZF, Yu GP, et al. Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Am J Epidemiol 2013;178(5):679.
  5. Lang K, Menzin J, Earle CC, et al. The economic cost of squamous cell cancer of the head and neck: findings from linked SEER–Medicare data. Arch Otolaryngol Head Neck Surg 2004; 130:1269–1275.
  6. Licitra L, Felip E. Squamous cell carcinoma of the head and neck: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Annals of Oncology 2009;20:121-122.
  7. Warnakulasuriya S. Prognostic and Predictive Markers for Oral Squamous Cell Carcinoma: The Importance of Clinical, Pathological and Molecular Markers. Saudi Journal of Medicine & Medical Sciences 2014; 2(1):12-16.
  8. Jerjes W, Upile T, Radhi H, Petrie A, Abiola J, Adams A,et al. The effect of tobacco and alcohol and their reduction/cessation on mortality in oral cancer patients: Short communication. Head Neck Oncol   2012; 4:6.
  9. Kademani D, Bell RB, Bagheri S, Holmgren E, Dierks E, Potter B, et al. Prognostic factors in intra oral squamous cell carcinoma: The influence of histologic grade. J Oral Maxilofac Surg 2005;63:1599-605.
  10. Ganly I, Goldstein D, Carlson DL, Patel SG, O’Sullivan B, Lee N,et al. Long-term regional control and survival in patients with “low-risk,” early stage oral tongue cancer managed by partial glossectomy and neck dissection without postoperative radiation: The importance of tumour thickness. Cancer 2013;119:1168-76.
  11. Sawair FA, Irwin CR, Gordon DJ, Leonard AG, Stephenson M, Napier SS. Invasive front grading and usefulness in the management of oral squamous cell carcinoma. J Oral Pathol Med 2003;32:1-9.
  12. Dissanayake U, Johnson NW, Warnakulasuriya KA. Comparison of cell proliferation in the centre and advancing fronts of oral squamous cell carcinomas using Ki-67 index. Cell Prolif 2003;36:255-64.
  13. Rahima B, Shingaki S, Nagata M, Saito C. Prognostic significance of perineural invasion in oral and orophayngeal carcinoma. Oral Surg 2004;97:423-31.
  14. Bailey JS, Blanchaert RH JR., Ord RA. Management of oral squamous cell carincoma treated with inadequate excisional biopsy. J Oral Maxillofac Surg 2001;59:1007-11.
  15. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM. Human papillomavirus positive squamous cell carcinomas of the oropharynx. Cancer 2001;92:805-13.